Bluejay Diagnostics, Inc.
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2022
- $249.0K
- Net income
- -$6.8M
- Total assets
- $7.1M
- Market cap
- $5.0M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $5.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 10, 2021
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Bluejay Diagnostics, Inc..